Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
3 Meme Stocks That Are Likely to Crater in 2024
06:47am, Tuesday, 14'th May 2024
Meme stocks have the potential to completely change the portfolio health even with a limited exposure of 5% to 10%. The best example now is Carvana (NYSE: CVNA ), which surged from under-$5 levels at
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
05:11am, Tuesday, 14'th May 2024
Novavax stock more than doubled in response to a licensing deal with a big pharma partner. Sanofi will give Novavax $500 million up front to co-license and co-commercialize its COVID-19 vaccine.
Novavax to Participate in BofA Securities 2024 Health Care Conference
04:02pm, Monday, 13'th May 2024
GAITHERSBURG, Md. , May 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
01:56pm, Monday, 13'th May 2024
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination vaccines. This announcement even overshadows the dismal Q1 results.
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
01:37pm, Monday, 13'th May 2024
Novavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year due to doubts about staying afloat.
Meme Mania is Back: Buy these 3 Stocks
01:01pm, Monday, 13'th May 2024
Monday's market action tells us that meme stocks are back in play. However, because not all meme stocks are created equally, investors should focus on those with fundamental catalysts.
Novavax: Sanofi Partnership Revitalizes My Magnum Opus
01:07pm, Sunday, 12'th May 2024
Novavax announced Q1 2024 results with a beat on EPS and a miss on revenue, causing a surge in premarket trading. Novavax finalized a licensing agreement with Sanofi worth up to $1.2B, boosting its CO
Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript
07:50am, Sunday, 12'th May 2024
Novavax, Inc. (NASDAQ:NVAX ) Q1 2024 Earnings Conference Call May 10, 2024 8:30 AM ET Company Participants Erika Schultz - Senior Director of Investor Relations John Jacobs - President and Chief Execu
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal
01:20pm, Friday, 10'th May 2024
Novavax shares soared after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Madison Muller reports on Bloomberg Televi
Why Novavax Stock More Than Doubled Today
01:08pm, Friday, 10'th May 2024
The pharmaceutical company saw measurable but modest growth last quarter, but remains in the red. Its vaccine science, however, has motivated a rival drugmaker to enter into a lucrative partnership.
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
01:02pm, Friday, 10'th May 2024
Novavax (NASDAQ: NVAX ) stock investors are celebrating on Friday as the vaccine company's shares hit a new 52-week high after announcing a deal with Sanofi (NASDAQ: SNY ). This saw shares of NVAX s
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
12:28pm, Friday, 10'th May 2024
Novavax (NASDAQ: NVAX ) stock has more than doubled today and is up more than 120% at the time of this writing. This morning, the company announced a co-exclusive licensing agreement with Sanofi (NASD
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi
12:24pm, Friday, 10'th May 2024
Novavax, Inc. (NASDAQ:NVAX) shares surged Friday following the announcement of a significant licensing agreement with Sanofi SA (ADR) (NYSE:SNY), valued at $1.2 billion. The deal encompasses the comme
Novavax (NVAX) Deal with Sanofi to Co-Commercialize Covid Vaccine
12:14pm, Friday, 10'th May 2024
Novavax (NVAX) signed a deal with drugmaker Sanofi to co-commercialize the Covid Vaccine. Diane King Hall discusses this, as well as Novavax's 1Q earnings.
Novavax stock soars on $1.2 billion Sanofi vaccine deal
11:58am, Friday, 10'th May 2024
Novavax (NVAX) shares are skyrocketing after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu shot. Yahoo Finance's Anjalee Khemlani joins The Morning Brie
